Atezolizumab SBRT S1914 SWOG Phase 3 Results [2022] Non-Small Cell Lung Cancer 8 Mins Read0 Does Atezolizumab SBRT Improve Progression-Free Survival In NSCLC? Atezolizumab is an immune checkpoint inhibitor that targets PDL-1. It has been…
